Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Cartesian Therapeutics (RNAC) Long-Term Debt Repayments (2017 - 2023)

Historic Long-Term Debt Repayments for Cartesian Therapeutics (RNAC) over the last 5 years, with Q3 2023 value amounting to $24.9 million.

  • Cartesian Therapeutics' Long-Term Debt Repayments changed N/A to $24.9 million in Q3 2023 from the same period last year, while for Dec 2024 it was $24.9 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $27.5 million for FY2023, which is N/A changed from last year.
  • As of Q3 2023, Cartesian Therapeutics' Long-Term Debt Repayments stood at $24.9 million.
  • In the past 5 years, Cartesian Therapeutics' Long-Term Debt Repayments registered a high of $24.9 million during Q3 2023, and its lowest value of $700000.0 during Q3 2019.
  • Its 3-year average for Long-Term Debt Repayments is $7.8 million, with a median of $2.1 million in 2019.
  • Data for Cartesian Therapeutics' Long-Term Debt Repayments shows a peak YoY increase of 205900.0% (in 2020) and a maximum YoY decrease of 205900.0% (in 2020) over the last 5 years.
  • Over the past 3 years, Cartesian Therapeutics' Long-Term Debt Repayments (Quarter) stood at $2.1 million in 2019, then skyrocketed by 619.67% to $15.1 million in 2020, then soared by 64.57% to $24.9 million in 2023.
  • Its last three reported values are $24.9 million in Q3 2023, $15.1 million for Q3 2020, and $2.1 million during Q2 2020.